A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Clinical trial NCT02597933 · COMPLETED

Trial details

NCT number: NCT02597933
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Scleroderma, Systemic

Start date: 2015-11-12
Primary completion: 2018-10-31
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.